Edap Tms (NASDAQ:EDAP) Stock Rating Upgraded by StockNews.com

Edap Tms (NASDAQ:EDAP) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $19.00 target price on shares of Edap Tms in a research report on Friday, May 17th.

Edap Tms Trading Down 0.9 %

Shares of NASDAQ EDAP opened at $5.25 on Tuesday. The company has a quick ratio of 2.00, a current ratio of 2.62 and a debt-to-equity ratio of 0.08. The business has a fifty day simple moving average of $6.04 and a two-hundred day simple moving average of $6.35. The firm has a market cap of $194.78 million, a PE ratio of -9.72 and a beta of 0.45. Edap Tms has a twelve month low of $3.60 and a twelve month high of $9.53.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Thursday, May 16th. The medical equipment provider reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.03). The company had revenue of $16.13 million during the quarter, compared to the consensus estimate of $16.22 million. Edap Tms had a negative return on equity of 31.44% and a negative net margin of 30.12%. Analysts expect that Edap Tms will post -0.51 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Edap Tms

A number of hedge funds have recently made changes to their positions in EDAP. Rock Springs Capital Management LP raised its holdings in shares of Edap Tms by 14.6% during the third quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock valued at $9,547,000 after acquiring an additional 173,700 shares during the last quarter. Miracle Mile Advisors LLC acquired a new position in shares of Edap Tms during the first quarter valued at approximately $136,000. Roubaix Capital LLC acquired a new position in shares of Edap Tms during the first quarter valued at approximately $169,000. Finally, Virtu Financial LLC acquired a new position in shares of Edap Tms during the first quarter valued at approximately $82,000. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.